Trials / Completed
CompletedNCT01739322
Biological Standardization of Platanus Acerifolia Allergen Extract
Biological Standardization of Platanus Acerifolia Allergen Extract to Determine the Biological Activity in HEP Units.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Laboratorios Leti, S.L. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine the biologic activity of a Platanus acerifolia allergen extract in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).
Detailed description
This is an open, unblinded and non-randomized biological assay. The study design is a slight modification of the recommendations proposed by the Nordic Guidelines. Four concentrations of Platanus acerifolia allergen extract, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Prick test Platanus acerifolia allergen extract | This is an open, unblinded and non randomized biological as proposed by the Nordic Guidelines. Four concentrations of Platanus acerifolia allergen extract, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm. This test will be referred to as the Titrated Skin Prick test. |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2012-12-03
- Last updated
- 2018-02-23
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01739322. Inclusion in this directory is not an endorsement.